Previous 10 | Next 10 |
home / stock / tlt / tlt articles
The number of U.S. citizens filing new claims for unemployment benefits fell more sharply than expected last week, underpinning the Federal Reserve...
Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by th...
Wall Street witnessed slight gains at midday on Monday, with investors eagerly awaiting a series of critical earnings reports, the Federal Reserve&...
Over the past twenty days of trading, iShares 20+ Year Treasury Bond ETF (NASDAQ: TLT), from December 06, 2023 to January 04, 2024 there is a pote...
After a tumultuous cycle in the markets, the S&P 500 is on the brink of a breakout as investor sentiment shifts, according to a senior portfoli...
U.S. 30-year Treasury yields fell below the 4% mark on Wednesday, reaching their lowest level since late July. The decline in long-dated Treasury y...
The CEO of Howard Capital Management, Vance Howard, has made predictions about the financial markets that may surprise some investors. Despite the ...
Treasury auctions are coming under scrutiny for the latest signs of stress in the government bond market. What Happened: The U.S. looks to raise hi...
U.S. stocks marked their fourth consecutive week of gains, the longest winning streak since June, in a week marked by thinner trading volumes due t...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their form...